Mary Ann Gray - Insider Trading & Ownership

Location
201 W 70 Th St, Suite 23 K, New York, NY
Summary
The estimated net worth of Mary Ann Gray is at least $1.17M dollars as of June 18, 2025. Mary Ann Gray is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $993K. Mary Ann Gray is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $75.8K. Mary Ann Gray is the Director of RAPT Therapeutics, Inc. and owns shares of RAPT Therapeutics, Inc. (RAPT) stock worth about $65K. Mary Ann Gray is the Director of BioAtla, Inc. and owns shares of BioAtla, Inc. (BCAB) stock worth about $33.3K. Mary Ann Gray is the Director of PALISADE BIO, INC. and owns shares of PALISADE BIO, INC. (PALI) stock worth about $2.97K.
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Mary Ann Gray
All Insider Reports
All Insider Reports

Ownership of Mary Ann Gray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. Director $993K Mar 7, 2022
KROS Keros Therapeutics, Inc. Director $75.8K Jun 4, 2025
RAPT RAPT Therapeutics, Inc. Director $65K May 29, 2025
BCAB BioAtla, Inc. Director $33.3K Jun 18, 2025
PALI PALISADE BIO, INC. Director $2.97K Nov 21, 2023
CMPX Compass Therapeutics, Inc. Director Feb 11, 2025

Insider Transactions Reported by Mary Ann Gray:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.